Physician profile
Jiyoung Kim
NPI 1710076070
$1,467.90
in general payments reported to CMS, 2019-2025
12 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Prosthodontics provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $32.43 · 2021: $499 · 2022: $30.03 · 2023: $457 · 2024: $52.26 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $425 · Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $425.00 |
| Food and Beverage | $324.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $586.30 | 2021-2023 | |
| Straumann USA LLC | $440.29 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $124.99 | 2019 | |
| Nobel Biocare USA | $57.37 | 2023 | Nobelactive |
| Dentsply Sirona INC | $52.32 | 2019-2025 | X-Smart |
| Premier Dental Products Company | $47.32 | 2023 | Zr-Cem, Aeropro Cordless Handpiece |
| 3m Company | $38.28 | 2023 | Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Filtek |
| Solventum Corporation | $37.58 | 2024 | Clarity Aligners, 3m Filtek, 3m Scotchbond |
| Orapharma, A Division of Bausch Health US, LLC | $34.29 | 2024-2025 | Ossix Plus, Arestin |
| Kulzer, LLC | $19.14 | 2020 | |
| Biolase, INC. | $16.73 | 2023 | Waterlase Iplus |
| Biohorizons Implant Systems INC. | $13.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jiyoung Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.